ARLINGTON HEIGHTS, IL — The landscape of breast surgery informed consent is on the cusp of a significant transformation. The Breast Surgery Collaborative Community (BSCC), a multi-stakeholder coalition comprising patients, board-certified plastic surgeons, and industry representatives, has officially submitted a proposal to the U.S. Food and Drug Administration (FDA) to overhaul the current Breast Implant Patient Decision Checklist.
For years, the medical community has grappled with the balance between comprehensive regulatory disclosure and the practical limitations of the clinical consultation room. Now, the BSCC is inviting the public to weigh in on a revised version of the checklist, aiming to distill complex safety data into a more accessible, actionable, and meaningful educational tool.
The Genesis of the Checklist: A Chronology of Informed Consent
To understand the necessity of this proposal, one must look at the evolution of FDA oversight regarding breast implants.
The 2022 Implementation
In 2022, the FDA introduced a mandatory Patient Decision Checklist as part of its updated safety requirements for breast implants. The goal was noble: to ensure that patients—particularly those undergoing breast augmentation or reconstruction—were fully aware of the risks, including the potential for complications, reoperation, and the rare but serious association with Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and Breast Implant Illness (BII) symptoms.
The Growing Pains
While the intent behind the 2022 checklist was to empower patients, the reality of its implementation quickly drew criticism. Clinicians reported that the document was excessively lengthy and dense with technical jargon. Surgeons noted that the time required to review the document often detracted from the quality of the interpersonal, shared decision-making process. Patients, meanwhile, expressed feeling overwhelmed rather than informed, describing a document that felt like a "legal shield" for manufacturers rather than an educational guide for their own health journeys.
The Consensus-Based Pivot
Recognizing these challenges, the BSCC—an organization formed to bridge the gap between regulatory bodies, patients, and surgeons—launched a multi-year, consensus-based effort. Over the last several years, this group, which includes advocates from organizations like the Breast Implant Safety Alliance and the Young Survival Coalition, worked to synthesize feedback from the front lines of clinical practice. The result is a revised document that prioritizes clarity, readability, and patient-centered design.
Supporting Data: Why "More" Isn’t Always "Better"
The drive toward a shorter, more concise checklist is supported by established principles of health literacy. Research consistently shows that when patients are presented with an overload of information, their ability to retain and understand critical safety details decreases.
The Burden of Cognitive Overload
In the context of plastic surgery, patients are often managing significant emotional and physical stress. A multi-page document filled with dense text and regulatory legalese can inadvertently cause "information fatigue." By streamlining the checklist, the BSCC aims to:
- Improve Retention: Focusing on the most pertinent safety data allows patients to better grasp the risks and benefits.
- Enhance Engagement: A shorter document serves as a conversation starter rather than a static form, encouraging patients to ask deeper, more relevant questions during their consultation.
- Standardize Quality: A more usable tool is more likely to be utilized consistently across different practices, ensuring a baseline standard of care for every patient, regardless of their location.
Official Responses and Collaborative Perspectives
The strength of the BSCC’s proposal lies in the diversity of its membership. The group is not merely a medical organization; it is a collaborative community in the truest sense, integrating the voices of those who live with implants alongside those who design and implant them.
A Unified Front
The committee responsible for the revision includes high-ranking members of the American Society of Plastic Surgeons (ASPS) and The Aesthetic Society, alongside dedicated patient advocates. This ensures that the document does not sacrifice clinical accuracy for brevity.
"Our goal was never to remove information," said a representative from the BSCC during the announcement. "Our goal was to refine how that information is delivered. We want to ensure that when a patient signs that checklist, they are not just checking a box, but confirming that they have had a meaningful, high-quality conversation with their surgeon."
The Role of Industry
Even representatives from major manufacturers—including Mentor Worldwide LLC, Establishment Labs, and Sientra—have participated in the collaborative effort. Their inclusion provides a transparent view of device technology and safety profiles, ensuring that the checklist reflects the current state of medical device engineering while remaining grounded in the lived experience of patients.

Implications for the Future of Shared Decision-Making
The BSCC’s proposal has profound implications for the future of elective and reconstructive surgery. If adopted by the FDA, this shift could set a new precedent for how regulatory bodies interact with medical professionals and patients.
Strengthening the Surgeon-Patient Relationship
The "shared decision-making" model is a pillar of modern medicine. By removing the friction of an overly burdensome checklist, the BSCC hopes to give time back to the physician and patient. Instead of spending 20 minutes reviewing a dense document, that time can be reallocated to discussing a patient’s specific goals, their anatomy, and their personal risk factors.
Setting a Regulatory Standard
The BSCC operates within the framework of FDA Collaborative Communities. This model is designed to solve systemic problems that are too complex for any one stakeholder to tackle alone. If this initiative succeeds, it could serve as a template for other medical devices or surgical procedures that require complex informed consent processes.
How to Participate: A Call for Public Input
The BSCC is firm in its belief that the final document must reflect the needs of the people it is designed to protect. Consequently, the revised checklist is now available for public review.
Submission Guidelines
The FDA has opened a public docket to collect feedback on the proposal. Interested parties—patients, surgeons, nurses, and researchers—are encouraged to review the document and provide their thoughts.
- Submission Deadline: December 1, 2026.
- Link for Comments: https://www.regulations.gov/comment/FDA-2019-D-4467-1386
- Tracking Number: To ensure your feedback is categorized correctly under the BSCC proposal, please include the following tracking number in your submission: mt7-xgl2-2crx.
About the Breast Surgery Collaborative Community (BSCC)
The BSCC is a vital forum for communication between the FDA, medical professional organizations, and the public. By fostering a space where private- and public-sector members can align on common objectives, the community addresses the most pressing challenges in breast surgery.
Members represent a broad coalition of expertise, including:
- The American Society of Plastic Surgeons (ASPS)
- The Aesthetic Society
- The Plastic Surgery Foundation
- The Aesthetic Foundation
- Breast Implant Safety Alliance (BISA)
- Young Survival Coalition
- FORCE: Facing Our Risk of Cancer Empowered
By prioritizing patient advocacy alongside surgical excellence, the BSCC continues to push the boundaries of what is possible in safety and education.
Looking Ahead: The Path to Finalization
As the comment period progresses, the BSCC will review the feedback gathered from the public. This iterative process is the final step in a long journey toward a more effective informed consent experience.
For the patient, this means the possibility of a clearer path forward. For the surgeon, it means a more effective clinical tool. And for the FDA, it represents the success of the collaborative community model—a testament to what happens when all stakeholders sit at the same table to solve problems for the public good.
As we look toward the December 2026 deadline, the message from the BSCC is clear: the conversation about breast surgery safety is evolving, and everyone has a role to play in defining its future.
Members of the Breast Surgery Collaborative Community (BSCC)
- William P. Adams Jr., MD (The Aesthetic Society/The Aesthetic Foundation)
- Scot B. Glasberg, MD (ASPS/PSF)
- George Chatson, MD (ASPS/PSF)
- Jennifer Cook (Patient and Advocate, BISA)
- Lynn Damitz, MD (ASPS/PSF)
- Melinda Haws, MD (The Aesthetic Society/The Aesthetic Foundation)
- Amanda Hynum (Patient Advocate, Oregon Health and Science University)
- Cynthia Johnson, RN (Patient Advocate)
- Debra Johnson, MD (At Large PS Representative)
- Meristacia Kingston, MD (Patient Advocate, Pediatric Hospitalist Fellow)
- Patricia McGuire, MD (The Aesthetic Society/The Aesthetic Foundation)
- Kimberly Platt, MSN, RN, CAPA (Patient Advocate, Registered Nurse)
- Sheryl Robinson-Collins (Mentor Worldwide LLC)*
- Margie Rose, MPH (Establishment Labs/Motiva)*
- Sara Saul, PhD (Tiger Aesthetics/Sientra)*
- Briana Theroux (At Large Patient/Author/Nutrition Psychology)
- Jamil Ahmad, MD (The Aesthetic Society President – Ex-Officio)*
- C. Bob Basu, MD, MBA, MPH, FACS (ASPS President – Ex-Officio)*
*Non-voting members
